SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001571049-17-004655
Filing Date
2017-05-08
Accepted
2017-05-08 16:06:17
Documents
61
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q t1701431-10q.htm 10-Q 947904
2 EXHIBIT 31.1 t1701431_ex31-1.htm EX-31.1 6688
3 EXHIBIT 31.2 t1701431_ex31-2.htm EX-31.2 6670
4 EXHIBIT 32.1 t1701431_ex32-1.htm EX-32.1 2780
5 EXHIBIT 32.2 t1701431_ex32-2.htm EX-32.2 2760
  Complete submission text file 0001571049-17-004655.txt   4459683

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pahc-20170331.xml EX-101.INS 1028479
7 XBRL SCHEMA FILE pahc-20170331.xsd EX-101.SCH 31637
8 XBRL CALCULATION FILE pahc-20170331_cal.xml EX-101.CAL 51728
9 XBRL DEFINITION FILE pahc-20170331_def.xml EX-101.DEF 108906
10 XBRL LABEL FILE pahc-20170331_lab.xml EX-101.LAB 306344
11 XBRL PRESENTATION FILE pahc-20170331_pre.xml EX-101.PRE 211948
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36410 | Film No.: 17822233
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences